GlaxoSmithkline (GSK) Consumer Healthcare May 10 reported 34.60 per cent increase in standalone net profit at Rs 285.11 crore for the fourth quarter ended March 31, 2019. The company clocked a profit of Rs 211.81 crore in the January-March quarter a year ago, it said in a BSE filing.
Total income in the latest quarter was up 11.48 per cent to Rs 1,408.95 crore as against Rs 1,263.75 crore in the year-ago period.
Total expenses in the March quarter 2019 were Rs 982.70 crore, up 4 per cent from Rs 944.86 crore in the year-ago period.
For 2018-19, the company registered a profit of Rs 982.80 crore, a rise of 40.37 per cent from Rs 700.10 crore logged in 2017-18.
Total income during 2018-19 stood at Rs 5,214.61 crore as against Rs 4,634.46 crore in the previous year.
In a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10 each.
Shares of the company settled at Rs 7,035.85 per scrip on BSE, down 0.70 per cent from previous close.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
